Pelizaeus-Merzbacher Disease
Neurology·MeSH: Pelizaeus-Merzbacher Disease
Prevalence
0.5 / 100K
2 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| ion356 | IONIS PHARMACEUTICALS INC (IONS) |
Preclinical(1)
| Drug | Company |
|---|---|
| sc379 | Sana Biotechnology, Inc. (SANA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Pelizaeus-Merzbacher Disease?
BioSniper tracks 2 drugs in development for Pelizaeus-Merzbacher Disease across 2 companies.
How many clinical trials target Pelizaeus-Merzbacher Disease?
There are 3 clinical trials targeting Pelizaeus-Merzbacher Disease tracked by BioSniper.
What is the prevalence of Pelizaeus-Merzbacher Disease?
The estimated prevalence of Pelizaeus-Merzbacher Disease is approximately 0.5 per 100,000 population.
Deep-dive into Pelizaeus-Merzbacher Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis